巨星医疗控股(02393)公布中期业绩 公司拥有人应占溢利576.1万元 同比减少99.47%

Core Insights - Giant Medical Holdings (02393) reported a mid-year performance for 2025, with revenue from continuing operations approximately 803 million, representing a year-on-year decrease of 36.99% [1] - The profit attributable to the company's owners was 5.761 million, a significant decline of 99.47% year-on-year, with earnings per share at 0.25 cents [1] - The decline in revenue and gross margin was primarily attributed to the impact of China's centralized procurement policy on the medical segment, which is the main source of the group's income [1]